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Abstract
Background: To estimate the association between body-mass index (BMI: kg/m2) and colorectal
cancer (CRC) screening among US adults aged ≥ 50 years.
Methods: Population-based data from the 2001 Behavioral Risk Factor Surveillance Survey. Adults
(N = 84,284) aged ≥ 50 years were classified by BMI as normal weight (18.5–<25), overweight (25–
<30), obesity class I (30–<35), obesity class II (35–<40), and obesity class III (≥ 40). Interval since
most recent screening fecal occult blood test (FOBT): (0 = >1 year since last screening vs. 1 =
screened within the past year), and screening sigmoidoscopy (SIG): (0 = > 5 years since last
screening vs. 1 = within the past 5 years) were the outcomes.
Results: Results differed between men and women. After adjusting for age, health insurance, race,
and smoking, we found that, compared to normal weight men, men in the overweight (odds ratio
[OR] 1.25, 95% CI = 1.05–1.51) and obesity class I (OR = 1.21, 95% CI = 1.03–1.75) categories
were more likely to have obtained a screening SIG within the previous 5 years, while women in the
obesity class I (OR = 0.86, 95%CI = 0.78–0.94) and II (OR = 0.88, 95%CI = 0.79–0.99) categories
were less likely to have obtained a screening SIG compared to normal weight women. BMI was not
associated with FOBT.
Conclusion: Weight may be a correlate of CRC screening behavior but in a different way between
men and women.
Background
Colorectal cancer (CRC) is the third most common cancer
in the United States with approximately 150,000 cases
annually leading to about 57,000 annual deaths [1]. A
prospective study of over 900,000 US adults found that,
compared to normal weight adults, death rates from CRC
were 20% to 84% higher in overweight and severely obese
men and 10% to 46% higher in overweight and severely
obese women [2]. Although other factors (e.g., age, family
history) also contribute to CRC risk, obesity is a signifi-
cant risk factor [1]. Thus, overweight and obese adults
should consider obtaining regular CRC screening because
early detection and intervention might reduce mortality
[1,3].
However, studies suggest that overweight and obese
women are more likely to delay cervical and breast cancer
screenings than normal weight women [4,5]. In contrast,
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data from the 2001 Behavioral Risk Factor Surveillance
Survey (BRFSS) indicates that, among men, overweight
and obesity associates with obtaining prostate-specific
antigen testing (Fontaine, Heo & Allison, under review).
Although these cancers are sex-specific, the disparity led
us to evaluate whether the obesity CRC screening associa-
tion differed between men and women.
Methods
The Center for Disease Control and Prevention's BRFSS
collects state-based data on preventive health practices
and risk behaviors in the non-institutionalized civilian
population aged ≥ 18 years [6]. The analyses we report are
derived from the 2001 BRFSS. Information on BRFSS
design and sampling methods are reported elsewhere
[7,8].
Study variables
Body mass index (BMI; kg/m2), calculated from self-
reported weight and height, was the predictor.
Outcomes were interval since the most recent use of fecal
occult blood test (FOBT), and sigmoidoscopy (SIG) in
adults aged ≥ 50 years who reported ever having had the
respective screening examination. BRFSS codes FOBT
responses as: 'within past year', 'within past 2 years',
'within past 5 years', '5 or more years ago', 'don't know/
not sure', or 'refused'. SIG is coded as: 'within past year',
'within past 2 years', 'within past 5 years', 'within past 10
years', '10 or more years ago', 'don't know/not sure', or
'refused'. Consistent with screening recommendations
[1], we dichotomized FOBT as 0 = > 1 year since last
screening vs. 1 = screened within the past year. For SIG,
the American Cancer Society recommends screening every
5 years for adults aged ≥ 501. Thus, SIG was dichotomized
as 0 = > 5 years since last screening vs. 1 = screened within
the past 5 years.
We included age, education, race, income, self-reported
general health status, smoking, employment, and health
insurance as covariates.
Statistical analysis
We grouped respondents into 5 BMI-defined categories
(18.5–<25 "normal weight", 25–<30 "overweight", 30–
<35 "obesity class I", 35–<40 "obesity class II", and ≥ 40
"obesity class III"). Respondents (n = 250; .3%) with
BMI's <18.5 ("underweight") were omitted from the
analyses.
We used multivariate logistic regression to estimate BMI-
screening associations by entering the BMI-defined cate-
gories and potential confounders into the model as either
continuous (e.g., age [including polynomials up to the
third order]) or dichotomous variables (e.g., health insur-
ance). Using the guidelines proposed by Greenland [9],
we retained covariates that were statistically significant at
the two-sided 0.20 alpha level or caused a ≥ 10% change
in any of the BMI-defined categories when deleted. As a
result, education, income, self-reported general health,
and employment were omitted. Responses coded as 'don't
know/not sure', or 'refused' were treated as missing varia-
bles and excluded from analyses, as were respondents
with missing data on any covariates. To ensure unbiased
general population estimates, we used sample weights
provided by the BRFSS. BMI categories were investigated
as 4 contrasts with the normal weight category serving as
the referent.
To evaluate whether sex moderated the BMI-screening
association, we ran adjusted logistic models that also
included BMI × sex interaction terms. Finally, because we
observed a significant BMI × sex interaction, we then ana-
lyzed the data for men and women separately. Analyses
were performed with SPSS 11.5.
Results
The mean age of the respondents was 65 years (median =
63). The mean BMI was 30.2 (median = 31) and 93%
reported having health insurance. Less than half reported
ever having either a screening FOBT or SIG (Table 1).
Among those who ever had a screening examination
54.1% of men and 52.7% of women (χ2(1) = 6.61, p =
.010) reported obtaining a screening FOBT within the pre-
vious year, and 84.4% of men and 80.3% of women
(χ2(1) = 98.4, p < 0.001) reported obtaining a screening
SIG within the previous 5 years.
BMI was not associated with obtaining a FOBT (OR's
ranged from 0.90 to 0.98). Compared to normal weight
adults, however, those in the overweight (OR = 1.15,
95%CI 1.02–1.31), obesity class I (1.21, 95%CI 1.09–
1.35), II (1.17, 95%CI 1.04–1.44) and III (1.27, 95%CI
1.05–1.58) categories were more likely to have obtained a
screening SIG within the previous 5 years (p's < 0.05).
The interaction effect between sex and BMI categories on
FOBT was not significant (χ2(4) = 8.64, p=.071). How-
ever, the interaction effect between sex and BMI categories
on SIG screening was significant, (χ2(4) = 114.03, p <
.0001). BMI was not associated with obtaining a FOBT for
either sex (OR's ranged from 0.87 to 1.05). However,
compared to normal weight men, men in the overweight
(1.25, 95%CI 1.05–1.51) and obesity class I (1.21 95%CI
1.03–1.75) categories were significantly more likely to
have obtained a screening SIG. In contrast, obesity class I
(0.86 95%CI 0.78–0.94) and II (0.88 95%CI 0.79–0.99)
women were less likely to have obtained a screening SIG
compared to normal weight women (see Figure 1).BMC Public Health 2004, 4:53 http://www.biomedcentral.com/1471-2458/4/53
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Discussion
These data support an association between BMI and
obtaining a screening SIG within the previous 5 years,
after smoking, health insurance, race, and age are taken
into account. Moreover, the BMI-SIG associations were
different between women and men. Women in the obes-
ity class I and II categories were less likely to obtain SIG
screening as a function of BMI. This is consistent with
associations between BMI and delayed cervical and breast
cancer screening [4,5]. On the other hand, men in the
overweight and obesity class I categories were more likely
to obtain a screening SIG.
The reasons for this disparity are unclear. Perhaps physi-
cians encourage cancer screening more vigorously among
their overweight and obese male patients. Differences
between men and women on factors such as self-esteem
and body image [10] may also contribute to explaining
the differential BMI-screening associations. These specula-
tions underscore the importance of identifying barriers
that might deter overweight and obese women from
obtaining screenings.
This study has limitations including: the BRFSS, a tele-
phone survey, is prone to measurement error; because the
BRFSS is an observational study, the BMI-screening asso-
ciations could be due to residual confounding or con-
founding from unmeasured variables; the cross-sectional
design did not allow testing causal inferences; and people
without telephones, approximately 3% of the US popula-
tion [6], are not surveyed through BRFSS.
Conclusions
These data indicate that weight may be a correlate of CRC
screening behavior but in a different way for men and
women.
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Table 1: Selected characteristics of respondents aged ≥ 50 years
Characteristic Value* N
Age, yrs 64.6 ± 10.1 84,284
Body mass index (BMI), kg/m2 30.2 ± 6.2 84,284
Sex, %
Men 38.2 32,179
Women 61.8 52,106
Race, %
White 82.3 68,639
Non-white 17.7 14,778
Health insurance, %
Yes 93.0 78,260
No 7.0 5,904
Smoking, %
Current smoker 18.2 15,265
Former smoker 35.4 29,709
Never smoker 46.4 38,959
Ever had fecal occult blood test (FOBT), %
Yes 43.0 37,498
No 53.9 49,123
Ever had screening sigmoidoscopy (SIG), %
Yes 45.3 39,574
No 51.1 46,584
Screening fecal occult blood test (FOBT), %
within past year 53.2 18,449
greater that 1 year 46.8 16,238
Screening sigmoidoscopy (SIG), %
within past 5 years 81.8 30,465
greater than 5 years 18.2 6,771
* Plus-minus values are means ± standard deviationBMC Public Health 2004, 4:53 http://www.biomedcentral.com/1471-2458/4/53
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Adjusted odds ratios (OR) for obtaining a screening sigmoidoscopy according to BMI-defined categories for men and women Figure 1
Adjusted odds ratios (OR) for obtaining a screening sigmoidoscopy according to BMI-defined categories for men and women * 
Significantly different from normal weight reference group at p < 0.05.
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